CAITLIN RIDEN: Open Payments
NPI 1881248664 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 9 payments from 4 companies in 2025. Trend: 2023 $189 · 2024 $259 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: VRAYLAR, INGREZZA, COBENFY, CAPLYTA.
Industry payments across VA — which companies pay providers there.
